Related Experiment Videos
Biology of nitric oxide in neuroimmunoregulation
1Department of Immunology, University of Glasgow, Scotland.
Annals of the New York Academy of Sciences
|November 25, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
IL-33 Exacerbates Periodontal Disease through Induction of RANKL.
Journal of dental research·2015
Regulation of delayed-type hypersensitivity to pathogens and alloantigens.
Immunology today·2014
An interleukin-33/ST2 signaling deficiency reduces overt pain-like behaviors in mice.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2013
A Residual Spatial Attention Graph Network for Sensorless Force Estimation in Teleoperated Robots.
Annals of the New York Academy of Sciences·2026
Exploring the Sensorimotor System's Role in Emotional Authenticity Discrimination: A ccPAS Study.
Annals of the New York Academy of Sciences·2026
Effects of Classical Music on Behavioral and Physiological Stress Markers in Socially Isolated Prairie Voles.
Annals of the New York Academy of Sciences·2026
Dual-Component Surface-Enhanced Raman Scattering Detection of Tetracycline Based on Aptamer-Regulated Catalytic Switch.
Annals of the New York Academy of Sciences·2026
Deep Learning-Based Intelligent Resource Management for Renewable Energy Engineering Projects.
Annals of the New York Academy of Sciences·2026
Rhythm Across Species: Situating Human Speech in a Comparative Framework.
Annals of the New York Academy of Sciences·2026
Epilepsy Is Part of the CNS Phenotype in Classic Infantile Pompe Disease.
Neurology. Genetics·2026
Torque Teno Virus in the vagina: potential influence on health and disease.
Clinics (Sao Paulo, Brazil)·2026
Mitochondrial Crossroads in Neurobiology: From Cellular Vulnerability to Therapeutic Opportunity.
Cellular and molecular neurobiology·2026
P7C3 Compounds as Targeted Mitochondrial Therapeutics for Brain Disorders.
CNS neuroscience & therapeutics·2026